Clinical Trial

Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
Patients with thoracic esophageal squamous cell carcinoma after total two-field lymph node dissection were randomized into the adjuvant chemotherapy group or the postoperative observation group
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2019-11-21; most recent amendment 2026-07-19.
Trial Details
NCT Number NCT04174079
Lead Sponsor Sun Yat-Sen University Cancer Center
Conditions Thoracic Esophageal Squamous Cell Carcinoma
Enrollment 232 participants
Start Date 2019-12-11
Primary Completion 2029-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-21